|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM324472390 |
003 |
DE-627 |
005 |
20250301122853.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202008802
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1081.xml
|
035 |
|
|
|a (DE-627)NLM324472390
|
035 |
|
|
|a (NLM)33893670
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Zhang, Ming
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Upregulating Aggregation-Induced-Emission Nanoparticles with Blood-Tumor-Barrier Permeability for Precise Photothermal Eradication of Brain Tumors and Induction of Local Immune Responses
|
264 |
|
1 |
|c 2021
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 24.07.2024
|
500 |
|
|
|a Date Revised 24.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2021 Wiley-VCH GmbH.
|
520 |
|
|
|a Compared to other tumors, glioblastoma (GBM) is extremely difficult to treat. Recently, photothermal therapy (PTT) has demonstrated advanced therapeutic efficacy; however, because of the relatively low tissue-penetration efficiency of laser light, its application in deep-seated tumors remains challenging. Herein, bradykinin (BK) aggregation-induced-emission nanoparticles (BKAIE NPs) are synthesized; these offer selective penetration through the blood-tumor barrier (BTB) and strong absorbance in the near-infrared region (NIR). The BK ligand can prompt BTB adenosine receptor activation, which enhances transportation and accumulation inside tumors, as confirmed by T1 -weighted magnetic resonance and fluorescence imaging. The BK@AIE NPs exhibit high photothermal conversion efficiency under 980 nm NIR laser irradiation, facilitating the treatment of deep-seated tumors. Tumor progression can be effectively inhibited to extend the survival span of mice after spatiotemporal PTT. NIR irradiation can eradicate tumor tissues and release tumor-associated antigens. It is observed that the PTT treatment of GBM-bearing mice activates natural killer cells, CD3+ T cells, CD8+ T cells, and M1 macrophages in the GBM area, increasing the therapeutic efficacy. This study demonstrates that NIR-assisted BK@AIE NPs represent a promising strategy for the improved systematic elimination of GBMs and the activation of local brain immune privilege
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a glioblastoma
|
650 |
|
4 |
|a immune response
|
650 |
|
4 |
|a magnetic resonance
|
650 |
|
4 |
|a photothermal therapy
|
650 |
|
7 |
|a Bradykinin
|2 NLM
|
650 |
|
7 |
|a S8TIM42R2W
|2 NLM
|
700 |
1 |
|
|a Wang, Wentao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mohammadniaei, Mohsen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zheng, Tao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Qicheng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ashley, Jon
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, Shunjie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sun, Yi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tang, Ben Zhong
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 33(2021), 22 vom: 23. Juni, Seite e2008802
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
773 |
1 |
8 |
|g volume:33
|g year:2021
|g number:22
|g day:23
|g month:06
|g pages:e2008802
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202008802
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 33
|j 2021
|e 22
|b 23
|c 06
|h e2008802
|